These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35089397)

  • 21. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.
    El Ouali S; Rubin DT; Cohen BL; Regueiro MD; Rieder F
    Curr Opin Gastroenterol; 2021 Jul; 37(4):313-319. PubMed ID: 33859104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.
    Calafat M; González-Muñoza C; Fortuny M; Roig C; Calm A; Mombiela A; Cañete F; Bertoletti F; González-González L; Teller-Martín M; Gordillo J; Mañosa M; Garcia-Planella E; Domènech E
    Aging Clin Exp Res; 2021 Aug; 33(8):2355-2359. PubMed ID: 34164799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry.
    Agrawal M; Brenner EJ; Zhang X; Colombel JF; Kappelman MD; Ungaro RC; ; Gearry RB; Kalpan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE
    J Crohns Colitis; 2021 May; 15(5):860-863. PubMed ID: 33232456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
    Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
    World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis.
    Chen L; Hu K; Cheng C; Hu Q; Zhang L; An T; Guo Y; Chen S; Duan G
    Int J Colorectal Dis; 2022 Nov; 37(11):2277-2289. PubMed ID: 36271206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.
    Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term.
    Neri B; D'Agostini G; Salvatori S; Mossa M; Bettin F; Mancone R; Marafini I; Lolli E; Calabrese E; Monteleone G; Biancone L
    Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):948-954. PubMed ID: 37505974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic.
    Vadan R; Iacob R; Costache R; Stroie T; Saizu IA; Iacob S; Gheorghe L; Diculescu M; Gheorghe C
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):549-553. PubMed ID: 33331349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.
    Khan N; Mahmud N
    Gastroenterology; 2021 Sep; 161(3):827-836. PubMed ID: 34048782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
    Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD.
    Bamias G; Kokkotis G; Christidou A; Christodoulou DK; Delis V; Diamantopoulou G; Fessatou S; Gatopoulou A; Giouleme O; Kafritsa P; Kalantzis C; Kapsoritakis A; Karatzas P; Karmiris K; Katsanos K; Kevrekidou P; Kosmidis C; Mantaka A; Mathou N; Michalopoulos G; Michopoulos S; Papaconstantinou I; Papatheodoridis G; Polymeros D; Potamianos S; Poulopoulos G; Protopapas A; Sklavaina M; Soufleris K; Theocharis G; Theodoropoulou A; Triantafillidis JK; Triantafyllou K; Tsiolakidou G; Tsironi E; Tzouvala M; Viazis N; Xourgias V; Zacharopoulou E; Zampeli E; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e810-e817. PubMed ID: 34402469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease.
    Reuken PA; Andreas N; Grunert PC; Glöckner S; Kamradt T; Stallmach A
    J Crohns Colitis; 2022 Feb; 16(2):251-258. PubMed ID: 34379729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
    Berte' R; Mazza S; Stefanucci MR; Noviello D; Costa S; Ciafardini C; Mileti E; Mapelli M; Pasqualato S; Pinto S; Favale A; Vecchi M; Neurath MF; Atreya R; Fantini MC; Facciotti F; Caprioli F
    J Crohns Colitis; 2021 May; 15(5):864-868. PubMed ID: 33211810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis.
    Hadi Y; Dulai PS; Kupec J; Mohy-Ud-Din N; Jairath V; Farraye FA; Kochhar GS
    Aliment Pharmacol Ther; 2022 Jan; 55(2):191-200. PubMed ID: 34904240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.
    Khan N; Mahmud N; Patel M; Sundararajan R; Reinisch W
    Aliment Pharmacol Ther; 2023 Apr; 57(7):800-807. PubMed ID: 36645110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of biologics in inflammatory bowel disease patients with COVID-19.
    Weissman S; Aziz M; Smith WL; Elias S; Swaminath A; Feuerstein JD
    Int J Colorectal Dis; 2021 Sep; 36(9):2051-2055. PubMed ID: 34131784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study.
    Peng YL; Chang CH; Wei SC; Huang TY; Tai WC; Hsu WH; Wu DC; Yen HH; Tai CM; Chang CW; Lin WC; Wang HY; Lin CC; Kuo CJ; Chiu CT; Lin CP; Lee HC; Wu JF; Chung CS
    J Formos Med Assoc; 2023 Oct; 122(10):1042-1049. PubMed ID: 37019722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT.
    Watanabe K; Nojima M; Nakase H; Sato T; Matsuura M; Aoyama N; Kobayashi T; Sakuraba H; Nishishita M; Yokoyama K; Esaki M; Hirai F; Nagahori M; Nanjo S; Omori T; Tanida S; Yokoyama Y; Moriya K; Maemoto A; Handa O; Ohmiya N; Tsuchiya K; Shinzaki S; Kato S; Uraoka T; Tanaka H; Takatsu N; Nishida A; Umeno J; Nakamura M; Mishima Y; Fujiya M; Tsuchida K; Hiraoka S; Okabe M; Toyonaga T; Matsuoka K; Andoh A; Hirota Y; Hisamatsu T;
    J Gastroenterol; 2023 Oct; 58(10):1015-1029. PubMed ID: 37561155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study.
    Meyer A; Semenzato L; Zureik M; Weill A; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2021 Jul; 54(2):160-166. PubMed ID: 34110040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan.
    Ando K; Fujiya M; Watanabe K; Hiraoka S; Shiga H; Tanaka S; Iijima H; Mizushima T; Kobayashi T; Nagahori M; Ikeuchi H; Kato S; Torisu T; Kobayashi K; Higashiyama M; Fukui T; Kagaya T; Esaki M; Yanai S; Abukawa D; Naganuma M; Motoya S; Saruta M; Bamba S; Sasaki M; Uchiyama K; Fukuda K; Suzuki H; Nakase H; Shimizu T; Iizuka M; Watanabe M; Suzuki Y; Hisamatsu T
    J Gastroenterol; 2021 Dec; 56(12):1062-1079. PubMed ID: 34611740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.